APA

Kaasenbrood L., Poulter N. R., Sever P. S., Colhoun H. M., Livingstone S. J., Boekholdt S. M., Pressel S. L., Davis B. R., van der Graaf Y. & Visseren F. L. J. (20171031). Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. : Circulation. Cardiovascular quality and outcomes.

Chicago

Kaasenbrood Lotte, Poulter Neil R, Sever Peter S, Colhoun Helen M, Livingstone Shona J, Boekholdt S Matthijs, Pressel Sara L, Davis Barry R, van der Graaf Yolanda and Visseren Frank L J. 20171031. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. : Circulation. Cardiovascular quality and outcomes.

Harvard

Kaasenbrood L., Poulter N. R., Sever P. S., Colhoun H. M., Livingstone S. J., Boekholdt S. M., Pressel S. L., Davis B. R., van der Graaf Y. and Visseren F. L. J. (20171031). Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. : Circulation. Cardiovascular quality and outcomes.

MLA

Kaasenbrood Lotte, Poulter Neil R, Sever Peter S, Colhoun Helen M, Livingstone Shona J, Boekholdt S Matthijs, Pressel Sara L, Davis Barry R, van der Graaf Yolanda and Visseren Frank L J. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. : Circulation. Cardiovascular quality and outcomes. 20171031.